Picture a football game between two pretty good teams. The home
team kicks off to the visitors, and they embark on a steady
march down the field, and score a touchdown. Looks like the
visitors would do pretty good. Might be a blowout. And then they
kick off to the other team. A few plays later, it’s tied. On
second thought, it might be a close contest after all.
Both
sides have scored points in the courtroom, but neither side has
delivered anything like an early knockout blow. Of course juries
are the lynchpin of our system of justice, and the task of
reading them has led to more frustrated legal experts then
gamblers betting on the outcome of that football game. But after
trying to clear the head of everything known pre-trial, and
trying to place myself on the jury, I’d have to say they have no
idea at the one week juncture. And that’s probably a good thing.
In a sporting contest, there is often a moment of separation,
where the better team begins to assert their dominance. That
might occur, the moment when the stronger case becomes apparent,
but it hasn’t happened yet.
These notes have often said the Scrushy case is interesting
on several levels. It has the topical elements of corporate
greed, but this is made even better as it is associated with
other hot topics like medical care and insurance. Does the
Scrushy case effect more than the business world? Is it just
about CEO’s and Boards and Shareholders? I think the industry is
at least important enough to mention, and although there are few
or no voices working on this angle, I will try to establish some
connections, in these documents, during the course of the trial.
It may be just a business trial, as opposed to something like
murder or smuggling, but it has more than its share of intrigue,
including betrayal, infidelity, a corporate secret society
(Parkman’s Family) eccentricity, lifestyles of the rich and
famous, a rags-to-riches-to-courtroom success story, and old
fashioned greed. And on the one hand, we have a not-all-good;
not-all-bad strong personality at the center of the defense,
while we have a government determined to stop corporate
corruption. Without overstating Scrushy, he is the stuff of
tragedy. He was a very ambitious man who’s ambition was his
downfall. There is, of course, more to it than that, and I will
also be building on this theme, in the coming months.
So now the trial has begun, where does it stand at one week:
The possibilities:
1. Scrushy didn’t do it. His corporate underlings turned on
him and hatched a fraud. When they were caught, they pointed to
Scrushy, and since he was the CEO, the government was only too
willing to accept him as the culprit.
2. Scrushy did it. He masterminded a fraud, and coerced his
employees to go along with it.
3. They all did it. Scrushy may have been involved in a fraud,
but it was no worse than the participation of his colleagues.
4. It was all a misunderstanding, the figures and money were
improperly handled by poor management (also noting Scrushy has
no business degree) and although money was missing, there was an
absence of criminal intent.
5. The government is tilting at windmills, and they saw a stock
sell-off during a downturn, as more than it really was.
So that’s what the jury is looking at, after one week at
Trial.
____________________________________________________________________________________
The forensic accountant continued with his testimony today,
and detailed the level of fraud that he and his team found, at
HealthSouth. He displayed a flow chart that was supposed to
depict the general method of accounting at the company. It went
like this: 1) First they would get the numbers, 2) then they
would do what they called a “First Run,” which was putting the
numbers in the books; 3) and then they would re-work the numbers
by adding fraudulent entries; 4) Then they would run the numbers
again to produce their financial statements; 5) and finally,
they would file the fraudulent document with the government.
He put up a chart that demonstrated the amount of fraudulent
money that was added to the books in each of the quarters of the
investigation. The numbers are in millions. The total is 2.7
billion.,
| |
Q1 |
Q2 |
Q3 |
Q4 |
Total |
|
| 1996 |
|
7.37 |
10.79 |
70.2 |
86.36 |
|
| 1997 |
14.7 |
75.73 |
109.95 |
169.60 |
386.04 |
|
| 1998 |
100.23 |
127.17 |
167.17 |
208.47 |
603.04 |
|
| 1999 |
85.43 |
129.79 |
63.80 |
123.84 |
402.95 |
|
| 2000 |
23.40 |
51.27 |
113.84 |
158.44 |
348.95 |
|
| 2001 |
60.53 |
228.0 |
120.04 |
167.46 |
526.03 |
|
| 2002 |
76.33 |
109.59 |
49.31 |
(9.87) |
225.43 |
|
| |
|
|
|
|
|
|
The witness detailed a number of methods used to hide or
inflate numbers, including a phantom stock deal. HealthSouth
sold their stock in CareMark, but they added it back to the
books as an asset, as if they still owned it. A year later, the
books indicated that they sold the CareMark stock, but they
didn’t have it to sell. Numbers and fraudulent supporting
documents were provided to their E&Y auditors.
This was pretty damning testimony, in the sense of providing
evidence that a fraud did occur at HealthSouth However next
week, when his testimony wraps up, and cross-examination begins,
the defense will likely establish that this information only
shows that a fraud occurred, but there is no way of telling,
from an examination of the numbers, exactly who it was the
perpetrated the fraud.